Spirepoint Private Client’s Amgen AMGN Stock Holding History

Spirepoint Private Client’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Sell	5,266 -337	-6%	-$115K	0.15%	88
2026 Q1	$1.97M	Sell	5,603 -279	-5%	-$99.5K	0.19%	82
2025 Q4	$1.93M	Sell	5,882 -22	-0.4%	-$6.98K	0.18%	79
2025 Q3	$1.67M	Buy	5,904 +471	+9%	+$137K	0.18%	83
2025 Q2	$1.52M	Sell	5,433 -3	-0.1%	-$850	0.17%	85
2025 Q1	$1.69M	Sell	5,436 -174	-3%	-$51.4K	0.22%	70
2024 Q4	$1.46M	Buy	5,610 +1,569	+39%	+$466K	0.18%	74
2024 Q3	$1.3M	Sell	4,041 -42	-1%	-$13.7K	0.17%	82
2024 Q2	$1.28M	Buy	4,083 +180	+5%	+$52.9K	0.18%	80
2024 Q1	$1.11M	Buy	+3,903	New	+$1.14M	0.17%	84

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Spirepoint Private Client's AMGN Position: Q2 2026 in Review

Spirepoint Private Client reduced its Amgen (AMGN) stake by 6% in Q2 2026, selling an estimated $115K and leaving 5,266 shares worth $1.91M. The position accounts for 0.15% of the portfolio, ranked #88.

Spirepoint Private Client first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.97M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Spirepoint Private Client held 5,266 shares of Amgen worth $1.91M as of Q2 2026.
Spirepoint Private Client sold 337 Amgen shares in Q2 2026, an estimated $115K.
Amgen made up 0.15% of Spirepoint Private Client's portfolio in Q2 2026, its #88 holding.
Spirepoint Private Client first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
Spirepoint Private Client's Amgen position peaked at $1.97M in Q1 2026.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.